Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 1/20 | 0.49 |
| ▸ | CA12 | O43570 | 1/20 | 0.48 |
| ▸ | CA1 | P00915 | 1/20 | 0.48 |
| ▸ | CA2 | P00918 | 1/20 | 0.48 |
| ▸ | CA3 | P07451 | 1/20 | 0.48 |
| ▸ | CA4 | P22748 | 1/20 | 0.48 |
| ▸ | CA6 | P23280 | 1/20 | 0.48 |
| ▸ | CA5A | P35218 | 1/20 | 0.48 |
| ▸ | CA7 | P43166 | 1/20 | 0.48 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.48 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.48 |
| ▸ | CA9 | Q16790 | 1/20 | 0.48 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.48 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.48 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.48 |
| ▸ | EGFR | P00533 | 1/20 | 0.46 |
| ▸ | SRC | P12931 | 1/20 | 0.46 |
| ▸ | MMP1 | P03956 | 3/20 | 0.43 |
| ▸ | FCER2 | P06734 | 3/20 | 0.43 |
| ▸ | ANPEP | P15144 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2790203 | 0.87 | ANPEP (0.50) | MMECA12CA1CA2CA3 | |
| SCHEMBL12933707 | 0.84 | CTSS (0.56) | — | |
| SCHEMBL12933693 | 0.82 | MME (0.52) | MMEEGFRSRCMMP8KMT2A | |
| SCHEMBL1068521 | 0.81 | HDAC3 (0.44) | MMEKMT2AALDH1A1MEN1CYP2D6 | |
| Hydrochloric Acid SCHEMBL2788161 | 0.81 | MME (0.51) | MMEEGFRSRCMMP8KMT2A | |
| Hydrochloric Acid SCHEMBL2788157 | 0.81 | MME (0.51) | MMEEGFRSRCMMP8KMT2A | |
| SCHEMBL16289738 | 0.79 | CA12 (0.49) | MMECA12CA1CA2CA3 | |
| SCHEMBL20720018 | 0.78 | MMP8 (0.61) | CA12CA1CA2CA3CA4 | |
| SCHEMBL12505312 | 0.78 | MMP8 (0.61) | CA12CA1CA2CA3CA4 | |
| SCHEMBL20485574 | 0.76 | CA12 (0.54) | CA12CA1CA2CA3CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7868206-B2 | Trihalomethionine derivative and pharmaceutical product containing the same | National University Corporation, Gunma University (JP) | 2011-01-11 | — | — | US | disclosed |
| US-20100076224-A1 | NOVEL TRIHALOMETHIONINE DERIVATIVE AND PHARMACEUTICAL PRODUCT CONTAINING THE SAME | NATIONAL UNIVERSITY CORPORATION GUNMA UNIVERSITY (JP) | 2010-03-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100076224-A1 | NOVEL TRIHALOMETHIONINE DERIVATIVE AND PHARMACEUTICAL PRODUCT CONTAINING THE SAME | CTH, MTR, BHMT | MME 772/4885CA12 4538/4885CA1 3851/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.